Global Plasma Fractionation Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Plasma Fractionation Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.

According to APO Research, The global Plasma Fractionation market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation.
The Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Fractionation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Plasma Fractionation segment by Type

Albumin
Immune Globulin
Coagulation Factor
Others
Plasma Fractionation segment by Application

Immunology
Hematology
Others
Plasma Fractionation by Distribution Channel

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Fractionation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Plasma Fractionation Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Plasma Fractionation Sales Estimates and Forecasts (2019-2030)
1.3 Plasma Fractionation Market by Type
1.3.1 Albumin
1.3.2 Immune Globulin
1.3.3 Coagulation Factor
1.3.4 Others
1.4 Global Plasma Fractionation Market Size by Type
1.4.1 Global Plasma Fractionation Market Size Overview by Type (2019-2030)
1.4.2 Global Plasma Fractionation Historic Market Size Review by Type (2019-2024)
1.4.3 Global Plasma Fractionation Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Plasma Fractionation Sales Breakdown by Type (2019-2024)
1.5.2 Europe Plasma Fractionation Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Plasma Fractionation Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Plasma Fractionation Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Plasma Fractionation Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Plasma Fractionation Industry Trends
2.2 Plasma Fractionation Industry Drivers
2.3 Plasma Fractionation Industry Opportunities and Challenges
2.4 Plasma Fractionation Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Plasma Fractionation Revenue (2019-2024)
3.2 Global Top Players by Plasma Fractionation Sales (2019-2024)
3.3 Global Top Players by Plasma Fractionation Price (2019-2024)
3.4 Global Plasma Fractionation Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Plasma Fractionation Key Company Manufacturing Sites & Headquarters
3.6 Global Plasma Fractionation Company, Product Type & Application
3.7 Global Plasma Fractionation Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Plasma Fractionation Market CR5 and HHI
3.8.2 Global Top 5 and 10 Plasma Fractionation Players Market Share by Revenue in 2023
3.8.3 2023 Plasma Fractionation Tier 1, Tier 2, and Tier 3
4 Plasma Fractionation Regional Status and Outlook
4.1 Global Plasma Fractionation Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Plasma Fractionation Historic Market Size by Region
4.2.1 Global Plasma Fractionation Sales in Volume by Region (2019-2024)
4.2.2 Global Plasma Fractionation Sales in Value by Region (2019-2024)
4.2.3 Global Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Plasma Fractionation Forecasted Market Size by Region
4.3.1 Global Plasma Fractionation Sales in Volume by Region (2025-2030)
4.3.2 Global Plasma Fractionation Sales in Value by Region (2025-2030)
4.3.3 Global Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Plasma Fractionation by Application
5.1 Plasma Fractionation Market by Application
5.1.1 Immunology
5.1.2 Hematology
5.1.3 Others
5.2 Global Plasma Fractionation Market Size by Application
5.2.1 Global Plasma Fractionation Market Size Overview by Application (2019-2030)
5.2.2 Global Plasma Fractionation Historic Market Size Review by Application (2019-2024)
5.2.3 Global Plasma Fractionation Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Plasma Fractionation Sales Breakdown by Application (2019-2024)
5.3.2 Europe Plasma Fractionation Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Plasma Fractionation Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Plasma Fractionation Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Plasma Fractionation Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Takeda
6.1.1 Takeda Comapny Information
6.1.2 Takeda Business Overview
6.1.3 Takeda Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Plasma Fractionation Product Portfolio
6.1.5 Takeda Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Plasma Fractionation Product Portfolio
6.2.5 CSL Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Plasma Fractionation Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Plasma Fractionation Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Kedrion
6.5.1 Kedrion Comapny Information
6.5.2 Kedrion Business Overview
6.5.3 Kedrion Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments
6.6 LFB Group
6.6.1 LFB Group Comapny Information
6.6.2 LFB Group Business Overview
6.6.3 LFB Group Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Plasma Fractionation Product Portfolio
6.6.5 LFB Group Recent Developments
6.7 Biotest
6.7.1 Biotest Comapny Information
6.7.2 Biotest Business Overview
6.7.3 Biotest Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Biotest Plasma Fractionation Product Portfolio
6.7.5 Biotest Recent Developments
6.8 BPL
6.8.1 BPL Comapny Information
6.8.2 BPL Business Overview
6.8.3 BPL Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Plasma Fractionation Product Portfolio
6.8.5 BPL Recent Developments
6.9 RAAS
6.9.1 RAAS Comapny Information
6.9.2 RAAS Business Overview
6.9.3 RAAS Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Plasma Fractionation Product Portfolio
6.9.5 RAAS Recent Developments
6.10 CBPO
6.10.1 CBPO Comapny Information
6.10.2 CBPO Business Overview
6.10.3 CBPO Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Plasma Fractionation Product Portfolio
6.10.5 CBPO Recent Developments
6.11 Hualan Bio
6.11.1 Hualan Bio Comapny Information
6.11.2 Hualan Bio Business Overview
6.11.3 Hualan Bio Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Bio Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments
7 North America by Country
7.1 North America Plasma Fractionation Sales by Country
7.1.1 North America Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Plasma Fractionation Sales by Country (2019-2024)
7.1.3 North America Plasma Fractionation Sales Forecast by Country (2025-2030)
7.2 North America Plasma Fractionation Market Size by Country
7.2.1 North America Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Plasma Fractionation Market Size by Country (2019-2024)
7.2.3 North America Plasma Fractionation Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Plasma Fractionation Sales by Country
8.1.1 Europe Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Plasma Fractionation Sales by Country (2019-2024)
8.1.3 Europe Plasma Fractionation Sales Forecast by Country (2025-2030)
8.2 Europe Plasma Fractionation Market Size by Country
8.2.1 Europe Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Plasma Fractionation Market Size by Country (2019-2024)
8.2.3 Europe Plasma Fractionation Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Plasma Fractionation Sales by Country
9.1.1 Asia-Pacific Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Plasma Fractionation Sales by Country (2019-2024)
9.1.3 Asia-Pacific Plasma Fractionation Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Plasma Fractionation Market Size by Country
9.2.1 Asia-Pacific Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Plasma Fractionation Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Plasma Fractionation Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Plasma Fractionation Sales by Country
10.1.1 Latin America Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Plasma Fractionation Sales by Country (2019-2024)
10.1.3 Latin America Plasma Fractionation Sales Forecast by Country (2025-2030)
10.2 Latin America Plasma Fractionation Market Size by Country
10.2.1 Latin America Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Plasma Fractionation Market Size by Country (2019-2024)
10.2.3 Latin America Plasma Fractionation Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Plasma Fractionation Sales by Country
11.1.1 Middle East and Africa Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Plasma Fractionation Sales by Country (2019-2024)
11.1.3 Middle East and Africa Plasma Fractionation Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Plasma Fractionation Market Size by Country
11.2.1 Middle East and Africa Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Plasma Fractionation Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Plasma Fractionation Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Plasma Fractionation Value Chain Analysis
12.1.1 Plasma Fractionation Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Plasma Fractionation Production Mode & Process
12.2 Plasma Fractionation Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Plasma Fractionation Distributors
12.2.3 Plasma Fractionation Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings